Effect of type of definitive treatment on race‐based differences in prostate cancer‐specific survival

Author:

Frego Nicola123,Labban Muhieddine12ORCID,Stone Benjamin V.12,Koelker Mara124,Alkhatib Khalid12,Lughezzani Giovanni3,Buffi Nicolò M.3,Lipsitz Stuart R.25,Weissman Joel S.2,Fletcher Sean A.6,Kibel Adam S.1ORCID,Trinh Quoc‐Dien12,Cole Alexander P.12ORCID

Affiliation:

1. Division of Urological Surgery, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

2. Center for Surgery and Public Health, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

3. Department of Urology Humanitas Research Hospital ‐ IRCCS Milan Italy

4. Department of Urology University Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Division of General Internal Medicine, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

6. Brady Urological Institute Johns Hopkins University School of Medicine Baltimore Maryland USA

Abstract

AbstractBackgroundRacial and ethnic disparities in prostate cancer (PCa) mortality are partially mediated by inequities in quality of care. Intermediate‐ and high‐risk PCa can be treated with either surgery or radiation, therefore we designed a study to assess the magnitude of race‐based differences in cancer‐specific survival between these two treatment modalities.MethodsNon‐Hispanic Black (NHB) and non‐Hispanic White (NHW) men with localized intermediate‐ and high‐risk PCa, treated with surgery or radiation between 2004 and 2015 in the Surveillance, Epidemiology and End Results database were included in the study and followed until December 2018. Unadjusted and adjusted survival analyses were employed to compare cancer‐specific survival by race and treatment modality. A model with an interaction term between race and treatment was used to assess whether the type of treatment amplified or attenuated the effect of race/ethnicity on prostate cancer‐specific mortality (PCSM).Results15,178 (20.1%) NHB and 60,225 (79.9%) NHW men were included in the study. NHB men had a higher cumulative incidence of PCSM (p = 0.005) and were significantly more likely to be treated with radiation than NHW men (aOR: 1.89, 95% CI: 1.81–1.97, p < 0.001). In the adjusted models, NHB men were significantly more likely to die from PCa compared with NHW men (aHR: 1.18, 95% CI: 1.03–1.35, p = 0.014), and radiation was associated with a significantly higher odds of PCSM (aHR: 2.10, 95% CI: 1.85–2.38, p < 0.001) compared with surgery. Finally, the interaction between race and treatment on PCSM was not significant, meaning that no race‐based differences in PCSM were found within each treatment modality.ConclusionsNHB men with intermediate‐ and high‐risk PCa had a higher rate of PCSM than NWH men in a large national cancer registry, though NHB and NHW men managed with the same treatment achieved similar PCa survival outcomes. The higher tendency for NHB men to receive radiation was similar in magnitude to the difference in cancer survival between racial and ethnic groups.

Publisher

Wiley

Subject

Urology,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3